Does small-sided-games’ court area influence metabolic,perceptual, and physical performance parameters of young elite basketball players?

The purpose of this study was to investigate the effect of court size on physiological responses and physical performance of young elite basketball players. Twelve male basketball players (18.6 ± 0.5 years; 88.8 ± 14.5 kg; 192.6 ± 6.5 cm) from an under-19 team performed two small-sided games (matches) with different court areas (28x15 m and 28x9 m; 28x15 and 28x9 protocols). The number of players (3x3) was kept the same in each protocol. The players performed a repeated-sprint ability (RSA) test before and after each match. Blood lactate concentration was collected before (pre) and after (post) the matches, and the session rating of perceived exertion (session-RPE) was determined 30 minutes after the match. Best and mean time in the RSA test were not different between the 28x15 and the 28x9 match protocols (p > 0.05). A significant difference was observed for lactate concentration from pre- to post-match (p < 0.05) in both protocols (28x15 and 28x9); however, there was no significant interaction between protocols. A similar session-RPE mean score (28x15: 7.2 ± 1.4 and 28x9: 6.6 ± 1.4) was detected for both protocols (p > 0.05, ES=0.41). In summary, the results of the current study suggest that the different court areas induced similar responses. Although there was no significant difference in effort perception, players tended to perceive a greater effort in the larger court size.     

Comparison of effects of static,proprioceptive neuromuscular facilitation and Mulligan stretching on hip flexion range of motion: a randomized controlled trial

The aim of this study was to compare the effects of static stretching, proprioceptive neuromuscular facilitation (PNF) stretching and Mulligan technique on hip flexion range of motion (ROM) in subjects with bilateral hamstring tightness. A total of 40 students (mean age: 21.5±1.3 years, mean body height: 172.8±8.2 cm, mean body mass index: 21.9±3.0 kg · m^-2) with bilateral hamstring tightness were enrolled in this randomized trial, of whom 26 completed the study. Subjects were divided into 4 groups performing (I) typical static stretching, (II) PNF stretching, (III) Mulligan traction straight leg raise (TSLR) technique, (IV) no intervention. Hip flexion ROM was measured using a digital goniometer with the passive straight leg raise test before and after 4 weeks by two physiotherapists blinded to the groups. 52 extremities of 26 subjects were analyzed. Hip flexion ROM increased in all three intervention groups (p<0.05) but not in the no-intervention group after 4 weeks. A statistically significant change in initial–final assessment differences of hip flexion ROM was found between groups (p<0.001) in favour of PNF stretching and Mulligan TSLR technique in comparison to typical static stretching (p=0.016 and p=0.02, respectively). No significant difference was found between Mulligan TSLR technique and PNF stretching (p=0.920). The initial–final assessment difference of hip flexion ROM was similar in typical static stretching and no intervention (p=0.491). A 4-week stretching intervention is beneficial for increasing hip flexion ROM in bilateral hamstring tightness. However, PNF stretching and Mulligan TSLR technique are superior to typical static stretching. These two interventions can be alternatively used for stretching in hamstring tightness.     

The association between sociodemographic,hormonal, tubo-ovarian factors and bacterial count in Chlamydia and Mycoplasma infections with infertility

Aim: To determine if there is an association between the Chlamydia and Mycoplasma infections with socio-demographic and clinical factors, and also with infertility. Methods: We conducted a study on 100 infertile married women and 100 control group, and collected data on the socio-demographic, hormonal and tubo-ovarian factors. The results of the endocervical swabs were analyzed for Mycoplasma and Chlamydia infection, the bacterial counts were also determined. Results: The percentage positivity to infection was significantly more among the infertile group compared to the control group, and also significantly more among the age group <30 years old. The positivity for infection with Chlamydia and/or Mycoplasma was significantly correlated with age, history of irregular menstruation, and history of previous abortion. Further sub-analysis of the infertile group showed that positivity to Chlamydia and/or Mycoplasma infection was significantly correlated to hormonal factors, ovarian factors, irregular menstruation, and previous abortion. Regression analysis showed that hormonal, ovarian factors, and irregular menstruation were the most significant factors in the positivity to Chlamydia and Mycoplasma infection. Bacterial count was significantly correlated with age, history of irregular menstruation, and history of previous abortion. Conclusion: Infection to Chlamydia and Mycoplasma is associated to younger age (?30 years old), and occurs in the infertile women. There is an interplay between infection in younger women, irregular menstruation, hormonal, and tubo-ovarian factors with infertility. Bacterial count was significantly correlated with age, history of irregular menstruation, and history of previous abortion.     

Site-specific mutations in HIV-1 gp41 reveal a correlation between HIV-1-mediated bystander apoptosis and fusion/hemifusion

The loss of CD4(+) T cells in HIV-1 infections is hypothesized to be caused by apoptosis of bystander cells mediated by cell surface-expressed HIV-1 Env glycoprotein. However, the mechanism by which Env mediates this process remains controversial. Specifically, the role of HIV-1 gp120 binding to CD4 and CXCR4 versus the fusion process mediated by gp41 remains unresolved. Env-induced apoptosis in bystander cells has been shown to be gp41-dependent and correlates with the redistribution of membrane lipids between Env-expressing cells and target cells (hemifusion). Using a rational mutagenesis approach aimed at targeting Env function via the gp41 subunit, we examined the role of HIV gp41 in bystander apoptosis. A mutation in the fusion domain of gp41 (V513E) resulted in a fusion-defective Env that failed to induce apoptosis. A mutation in the gp41 N-terminal helix (G547D) reduced cell fusion capacity and apoptosis; conversely, an Env mutant with a deletion of the gp41 cytoplasmic tail (Ct Del) enhanced both cell-to-cell fusion and apoptosis. Most significantly, an Env mutant containing a substitution in the loop region of gp41 (D589L) mediated transfer of lipids (hemifusion) to bystander cells but was defective in cell-to-cell and to a lesser degree virus-to-cell fusion. This mutant was still able to induce apoptosis in bystander cells. Hence, we have provided the first direct evidence that gp41-mediated hemifusion is both required and sufficient for induction of apoptosis in bystander cells. These results may help to explain the mechanism of HIV-1 Env-induced T cell depletion.     

Cover Image,Volume 120, Number 8, August 2019

Circular RNAs (circRNAs) are novel noncoding RNAs and play crucial roles in various biological processes. However, little is known about the functions of circRNAs in osteogenic differentiation. The current study aimed to investigate the differential expression of circRNAs in rat dental follicle cells (rDFCs) during osteogenic differentiation, identified by RNA high-throughput sequencing and quantitative real-time polymerase chain reaction. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to further explore the biofunctions of circRNA biofunctions. Two hundred sixty-six differentially-expressed circRNAs that are involved in several important signaling pathways, including mitogen-activated protein kinases (MAPK) and transforming growth factor-β (TGF-β) signaling pathways were revealed. Among these, circFgfr2 and its predicted downstream targets, miR-133 and BMP6 (bone morphogenetic protein-6), were identified both in vivo and in vitro. For further validation, circFgfr2 was overexpressed in rDFCs, the results showed that the expression of miR-133 was downregulated and the expression of BMP6 was upregulated. Taken together, the results revealed the circRNA expression profiles and indicated the importance of circRNAs of rDFCs. In addition, circFgfr2 might promote osteogenesis by controlling miR-133/BMP6, which is a potential new target for the manipulation of tooth regeneration and bone formation.     

Role of the Membrane-Proximal Domain in the Initial Stages of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein-Mediated Membrane Fusion

We have examined mutations in the ectodomain of the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 within a region immediately adjacent to the membrane-spanning domain for their effect on the outcome of the fusion cascade. Using the recently developed three-color assay (I. Muñoz-Barroso, S. Durell, K. Sakaguchi, E. Appella, and R. Blumenthal, J. Cell Biol. 140:315–323, 1998), we have assessed the ability of the mutant gp41s to transfer lipid and small solutes from susceptible target cells to the gp120-gp41-expressing cells. The results were compared with the syncytium-inducing capabilities of these gp41 mutants. Two mutant proteins were incapable of mediating both dye transfer and syncytium formation. Two mutant proteins mediated dye transfer but were less effective at inducing syncytium formation than was wild-type gp41. The most interesting mutant proteins were those that were not capable of inducing syncytium formation but still mediated dye transfer, indicating that the fusion cascade was blocked beyond the stage of small fusion pore formation. Fusion mediated by the mutant gp41s was inhibited by the peptides DP178 and C34.

The human immunodeficiency virus type 1 (HIV-1) gp120-gp41 fusion machine consists of an assembly of viral envelope glycoprotein oligomers which forms a molecular scaffold responsible for bringing the viral membrane close to the target cell membrane and creating the architecture that enables lipid bilayers to merge (7). The fusion reaction undergoes multiple steps before the final event occurs which allows delivery of the nucleocapsid into the cell. In the case of influenza virus hemagglutinin (HA), we have dissected these steps kinetically and analyzed the molecular features of the kinetic intermediates (1). In order to examine the modus operandi of the fusion machine, mutations in various domains of viral envelope glycoproteins have been examined for their effect on the outcome of the fusion cascade. For instance, replacement of the membrane-spanning domain of influenza virus HA with a glycosylphosphatidylinositol anchor results in a very stable hemifusion intermediate (6). Moreover, single-site mutations in the fusion peptide of HA significantly affect fusion pore dilation (9). Recently, cytoplasmic tail acylation mutants of influenza virus HA were identified which induce transfer of lipids and small aqueous molecules but do not induce syncytium formation (4a).High-resolution crystallographic determinations (4, 10, 11) of gp41 fragments from HIV-1 have revealed a bent-in-half, antiparallel, heterotrimeric coiled-coil structure. This is made up of a triple-stranded coiled coil of α-helices from the leucine zipper-like 4-3 repeat domain in gp41 close to the N-terminal fusion peptide termed HR1 (8) flanked by α-helices from the domain in gp41 close to the C-terminal membrane anchor termed HR2 (8). Comparison with the crystal structure of the influenza virus HA2 subunits in a low-pH-induced conformation (2) reveals common structural motifs which provide growing support for the “spring-loaded” type of mechanistic models (3). In this scenario, activation of the fusion protein results in release of the fusion peptide and extension of the central coiled-coil structure. The new positioning of the fusion peptides at the tip of the stalk provides for easy contact with the target cell membrane. A small group of proximal fusion proteins which are simultaneously inserted into both the viral and target membranes would constitute a potential fusion site. A concerted collapse of this protein complex, actuated by the bending in half of the stalks at a central hinge region, would presumably position the C-terminal transmembrane anchors and N-terminal fusion peptides on top of each other in the center, bring the two membranes into contact, and thus allow formation of the fusion pore (7). In this study, we examined the effects on the various stages of the fusion reaction of mutations in the region between HR2 and the transmembrane (TM) anchor (Fig. ​(Fig.1)1) described in detail by Salzwedel et al. (8a). Open in a separate windowFIG. 1Amino acid sequence and mutations in gp41. FP is the predicted fusion peptide region, and HR1 and HR2 (8) represent, respectively, the N-terminal and C-terminal α-helices of the triple-stranded coiled coil (4, 11). Mutations in the region between HR2 and the TM anchor include deletions of amino acids 665 to 682 and 678 to 682, insertion of a FLAG sequence (YKDDDD), insertion of a DAF sequence (PNKGSGTTS), scrambling of the underlined sequence to SC7 (INNWNFT), and replacement of the five tryptophans with alanines [W(1-5)A]. Peptide C34 represents HR2 amino acids 628 to 663, and peptide DP178 represents amino acids 638 to 673.Mutagenesis of HIV-1 env, construction of plasmids, cell surface expression, CD4 binding, and cell fusion were performed as previously described (8a). The simian virus 40-based env expression plasmids (1 μg of DNA) were transfected into COS-1 cells in 35-mm-diameter plates by using DEAE-dextran (1 mg/ml). At 14 h posttransfection, the cells were replated, and starting at 36 to 48 h posttransfection, they were incubated with 20 μM CMAC (7-amino-4-chloromethylcoumarin) in Dulbecco modified Eagle medium overnight at 37°C. All constructs expressed similar amounts of envelope glycoprotein on the cell surface (8a). The transfected cells were then washed and incubated in fresh medium for 2 h at 37°C before addition of HeLa-CD4 cells which were labeled in the membrane with octadecyl indocarbocyanine (DiI) and in the cytosol with calcein as previously described (7). The method used to detect cell-cell fusion was a three-color assay (7) based on the redistribution of fluorescent probes between effector and target cells upon fusion. The application of three different probes was used to monitor lipid versus cytosolic mixing in the same cell population. Fluorescently labeled gp120-gp41-expressing cells and CD4⁺ cells were cocultured at a 1:10 ratio for 2 h at 37°C in uncoated microwells (MatTek Corp., Ashland, Mass.). Bright-field and fluorescent images were acquired with an Olympus IX70 microscope coupled to a charge-coupled device camera (Princeton Instruments, Trenton, N.J.) with a 40× UplanApo oil immersion objective. Fluorescein isothiocyanate (exciter, BP470-490; beam splitter, DM505; emitter, BA515-550), rhodamine (exciter, BP530-550; beam splitter, DM570; emitter, BA590), and 4′,6-diamidino-2-phenylindole (DAPI) (exciter, D360/40; beam splitter, 400DCLP; emitter, D450/60) optical filter cubes were carefully chosen to avoid spillover when observing the fluorescence of the three dyes. For each sample, three or four different fields were collected, and data were analyzed by overlaying the images using Metamorph software (Universal Imaging Corporation, West Chester, Pa.). The percentage of lipid mixing and cytoplasmic mixing was calculated as 100 times the number of COS-1 cells stained with DiI and calcein divided by the total number of COS-1–HeLa-CD4 conjugates. Although not all COS-1 cells express env since the transfection efficiency is not 100%, env-expressing COS-1 cells are more likely to adhere to HeLa-CD4 cells.Figure ​Figure22 shows a montage of video images taken 2 h following incubation of COS-1 cells expressing wild-type (WT), W(1-5)A, and +DAF env with HeLa-CD4 cells at 37°C. As described in detail in the legend to Fig. ​Fig.2,2, we clearly observed COS-1 cells attached to HeLa-CD4 cells, which showed continuity of all three dyes (CMAC, calcein, and DiI). We know that for +DAF and W(1-5)A env-expressing COS-1 cells, these images do not represent syncytia since even small heterokaryons will show up in the MAGI cell assay (6a), which is based on the transfer of HIV-1 Tat coexpressed with env in COS-1 cells to HeLa-CD4 cells as a result of cell fusion. This transfer induces the expression of a β-galactosidase reporter gene engineered in HeLa-CD4 (MAGI) cells under the control of the viral long terminal repeat promoter (8a). Because the β-galactosidase has been modified to contain a nuclear targeting signal, the nuclei of the resulting heterokaryons stain dark blue with 5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside (X-Gal) in situ. The MAGI assay is extremely sensitive and clearly identifies syncytia as small as two nuclei. Such nuclei were common for the Δ678-682 mutant, which produced syncytia with an average size of ∼5 nuclei (Fig. ​(Fig.3).3). The assay can detect even a few of these fusion events per 100,000 cells. In the MAGI assay, we did not observe any blue nuclei with the W(1-5)A and +DAF constructs, an experiment repeated several times. The three-color assay therefore reveals a distinct phenotype exhibited by the +DAF and W(1-5)A mutant envelope glycoproteins, which form small fusion pores allowing movement of lipids and small molecules (<1,000 Da) but not of large molecules (HIV-1 Tat is about 14 kDa [4b]). Open in a separate windowFIG. 2Three-color assay for WT and mutant HIV-1 gp41s. Simian virus 40-based env expression plasmids (1 μg) containing WT (A to D), W(1-5)A (E to H), and +DAF (I to L) env genes were transfected into COS-1 cells in 35-mm plates using DEAE-dextran (1 μg/ml). At 14 h posttransfection, the cells were replated, and starting at 36 to 48 h posttransfection they were incubated with 20 μM CMAC in Dulbecco modified Eagle medium overnight at 37°C. All constructs expressed similar amounts of envelope glycoprotein on the cell surface (8a). The transfected cells were then washed and incubated in fresh medium for 2 h at 37°C before addition of HeLa-CD4 cells which were labeled in the membrane with DiI and in the cytosol with calcein as previously described (7). The COS-1 cells, labeled with CMAC, were cocultured 1:10 at 37°C for 2 h with HeLa-CD4 cells labeled with DiI and calcein, and images were examined by bright-field microscopy (A, E, and I) and fluorescence microscopy for CMAC staining (B, F, and J), for DiI staining (C, G, and K), and for calcein staining (D, H, and L). CMAC is a fluorescent chloromethyl derivative that freely diffuses through the membranes of live cells. Once inside the cell, this mildly thiol-reactive probe undergoes what is believed to be a glutathione S-transferase-mediated reaction to produce membrane-impermeant fluorescent dye adducts with glutathione, as well as with other intracellular components. Staining of COS-1 cells with CMAC gives rise to bright fluorescence due to reaction with proteins in the perinuclear, endoplasmic reticulum, and Golgi regions, which are immobile, as well as to weaker fluorescence due to the fluorescent glutathione adduct (molecular mass, ∼600 Da) in the cytosol, which is able to diffuse through small fusion pores. The COS-1 cells identified by CMAC staining (B, F, and J) are large and often appear multinuclear, although we do not know whether the round granular structures seen by bright-field microscopy of the COS-1 cells are nuclei or large granules. Panels A to D show one large cell triple stained with CMAC, DiI, and calcein (indicated by a star). DiI is internalized after 2 h at 37°C and appears punctate with nuclear sparing due to its localization in membranes of intracellular organelles. Calcein (465 Da) is evenly distributed throughout the cell (D). One large, granular COS-1 cell (A, left) is only stained with CMAC (B); its lack of staining with DiI (C) and calcein (D) indicates that it has not fused with HeLa-CD4 cells. In panel F, a large structure is seen which seems in continuity with CMAC. However, since the bottom left part of this structure is not in continuity with DiI (G) and calcein (H), it represent two cells. The top right cell (indicated by a star) is in continuity with CMAC, DiI, and calcein. Since COS-1 cells expressing W(1-5)A env do not produce blue nuclei when incubated with MAGI cells (see Fig. ​Fig.3),3), which requires transfer of the 14-kDa HIV-1 Tat protein (see text), we conclude that this COS-1–HeLa-CD4 conjugate represents a phenotype in which small fusion pores form, allowing movement of lipids and small molecules (<1,000 Da) but not of large molecules. The same phenotype is seen with COS-1 cells expressing DAF env: the COS-1–HeLa-CD4 conjugate indicated by a star in panels J, K, and L is in continuity with CMAC, DiI, and calcein but does not allow transfer of HIV-1 Tat (see Fig. ​Fig.33).Open in a separate windowFIG. 3Fusogenic activity of WT and mutant HIV-1 gp41s. The three-color assay was performed as described in the legend to Fig. ​Fig.2.2. Since multiple rounds of fusion may interfere with quantitation in the case of WT and mutant env genes which produce a large number of blue nuclei after 24 h at 37°C (grey bars), incubations were done for 2 h at 37°C. Black bars represent 100 times the number of COS-1 cells stained with DiI and calcein over the total number of COS-1–HeLa-CD4 conjugates measured in the three-color assay. The data are representative of five separate experiments. In each experiment, a total of 30 to 50 COS-1–HeLa-CD4 conjugates were counted. The number of nuclei per syncytium (grey bars) was obtained from the MAGI assay (8a) and represents the ability of HIV-1 Tat to transfer from COS-1 cells to HeLa-CD4 cells.We tallied data from many cell pairs similar to those shown in Fig. ​Fig.22 and plotted the average percentage of COS-1 cells stained with DiI and calcein. Figure ​Figure33 shows the data for the WT and a number of mutants described by Salzwedel et al. (8a). The data fall into three groups, in which the envelope glycoproteins mediate (i) both dye and HIV-1 Tat redistribution (WT, Δ678-682, and SC7), (ii) neither dye nor HIV-1 Tat redistribution (Δ665-682 and +FLAG), or (iii) dye but not HIV-1 Tat redistribution [W(1-5)A and +DAF]. The latter represents a nonexpanding fusion pore phenotype.Dye redistribution induced by WT and mutant gp41s was inhibited by the peptide inhibitors DP178 and C34 (Fig. ​(Fig.4).4). The latter peptide is from the HR2 sequence (residues 628 to 663) which forms the flanking peptide of the heterotrimeric coiled coil in the crystal structure. DP178 is frameshifted 10 amino acids toward the C terminus (residues 638 to 673). The inhibition data indicate that dye redistribution mediated by WT and mutant gp41 molecules is specific for the gp120-gp41-induced fusion reaction and not due to nonspecific transfer. Interestingly, W(1-5)A and SC7 exhibited greater sensitivity than the WT to DP178 inhibition. In the case of C34, inhibition was about the same for the WT and the two mutants. We observed no inhibition by DP178 or C34 of HIV-2 env-mediated fusion at up to 100 nM peptide (data not shown). Open in a separate windowFIG. 4Inhibition of cell-cell fusion by DP178 and C34 peptides. Cell fusion was calculated as a percentage of the control by using the three-color assay method shown in Fig. ​Fig.22 and ​and33 and described in the text for the WT, W(1-5)A, and SC7.Although the crystal structure of the gp41 core (4, 11) is based on the HR1-HR2 coiled coil, it is possible that in intact gp41 the bundle is extended to include amino acids downstream from HR2 and upstream from HR1. Extension of the coiled coil might lead to tilting of the TM anchor, which is presumably important for producing sufficient lipid curvature to form a fusion junction (1). Removal of amino acids 665 to 682 may leave no possibility to form this extended coiled coil. Similarly, insertion of the FLAG sequence, which contains four aspartic acid residues, would presumably insert charged residues into a hydrophobic domain, which could also prevent extension of the coiled coil. The other mutations presumably allow extended coiled-coil formation but reduce its efficiency because of weaker interactions between the amino acids in the extended region. The coiled-coil structure might be so frail in mutant gp41s W(1-5)A and +DAF that it is not present for a sufficient amount of time to create the fusion pore dilation necessary to allow transfer of HIV-1 Tat. Since the Δ678-682 and SC7 proteins are, to a limited extent, capable of inducing syncytium formation and dye transfer, we surmise that they possess intermediate extended coiled-coil-forming propensities.Based on the structural information about the gp41 core (4, 10, 11), it has been proposed that the binding site for the peptide inhibitors is in the HR1 bundle. The C34 and DP178 peptides presumably bind in the same way as the corresponding amino acid sequence regions of the three HR2 helices in the crystal structures. At this position, the peptides would sterically block the regular binding of the HR2 helices to the inner core of HR1 helices and thus prevent formation of the bent-in-half, antiparallel, heterotrimeric coiled-coil structure presumably required to bring the viral and target cell membranes into contact for fusion. Since C34 corresponds to HR2 with no amino acids in the extended region, we do not expect any enhanced inhibitory effect on fusion mediated by the mutant gp41s. Figure ​Figure4b4b shows that this is the case. Since DP178 does contain 10 amino acids downstream from HR2 whose interaction with amino acids upstream from HR1 is weaker in the mutants, we expect greater sensitivity to DP178 inhibition in the mutant proteins. This does seem to be the case, as shown in Fig. ​Fig.44a.The recent high-resolution X-ray crystallographic determination of the structure of the gp41 core from HIV-1 provides well-defined landmarks in the terrain the viral envelope glycoproteins navigate following CD4 and coreceptor-induced conformational changes (5). The structures include neither fusion peptides and TM anchors nor regions between those domains and HR1 and HR2, respectively, which are crucial for fusion activity. Therefore, mutagenesis of those undetermined domains combined with sensitive assays for the activity of the modified proteins will lead to refinement of our thinking about the HIV-1 gp120-gp41 fusion machine.     

Conformational intermediates and fusion activity of influenza virus hemagglutinin

Three strains of influenza virus (H1, H2, and H3) exhibited similar characteristics in the ability of their hemagglutinin (HA) to induce membrane fusion, but the HAs differed in their susceptibility to inactivation. The extent of inactivation depended on the pH of preincubation and was lowest for A/Japan (H2 subtype), in agreement with previous studies (A. Puri, F. Booy, R. W. Doms, J. M. White, and R. Blumenthal, J. Virol. 64:3824-3832, 1990). While significant inactivation of X31 (H3 subtype) was observed at 37 degrees C at pH values corresponding to the maximum of fusion (about pH 5.0), no inactivation was seen at preincubation pH values 0.2 to 0.4 pH units higher. Surprisingly, low-pH preincubation under those conditions enhanced the fusion rates and extents of A/Japan as well as those of X31. For A/PR 8/34 (H1 subtype), neither a shift of the pH (to >5.0) nor a decrease of the temperature to 20 degrees C was sufficient to prevent inactivation. We provide evidence that the activated HA is a conformational intermediate distinct from the native structure and from the final structure associated with the conformational change of HA, which is implicated by the high-resolution structure of the soluble trimeric fragment TBHA2 (P. A. Bullough, F. M. Hughson, J. J. Skehel, and D. C. Wiley, Nature 371:37-43, 1994).     

Redescription of a rare deep-sea batfish, <Emphasis Type="Italic">Halieutopsis bathyoreos</Emphasis> (Lophiiformes: Ogcocephalidae)

Halieutopsis bathyoreos Bradbury, 1988 (Lophiiformes: Ogcocephalidae), previously described only on the basis of the holotype (62.6mm in standard length) from the central North Pacific, is redescribed on the basis of the holotype and six additional specimens (41.2–68.7mm in standard length) collected from the western South Pacific, off Papua New Guinea, and the western North Pacific, including the Japanese Archipelago. Halieutopsis bathyoreos is distinguished from its congeners by having a shelflike rostrum extending anteriorly well beyond the mouth, a dorsal escal lobe slightly bisected ventrally, an illicial cavity square in outline and completely visible in ventral view, and lacking tubercles on the ventral surface of the disk. The following characters are newly added to the diagnoses of this species: rostrum width 21–29% of head length, tubercles on the dorsal surface of the disk about half the diameter of those on the lateral margin, and 13–15 large lateral-line scales on the tail.     

Triamterene-β-cyclodextrin systems: Preparation,characterization and in vivo evaluation

The purpose of this research was to improve the solubility and therefore dissolution and bioavailability of triamterene, a poorly water soluble diuretic, by complexation with β-cyclodextrin. Triamterene has been reported to show low bioavailability after oral administration, with wide intersubject variation. This study presents the formulation of solid dispersions of triamterene with β-cyclodextrin—by cogrinding, kneading, and coevaporation, using low pH conditions—and their characterizations, evaluation of improvement in dissolution profiles, and in vivo advantage. Phase solubility studies indicated complex with possible stoichiometry of 1∶1 and a stability constant of 167.67M⁻¹. The solid dispersions were characterized by Fourier transform infrared spectroscopy, nuclear magnetic resonance, x-ray diffraction, and differential scanning calorimetry studies. The characterization studies confirmed inclusion of the phenyl ring of triamterene within the nonpolar cavity of β-cyclodextrin in the coevaporate. Remarkable improvement in in vitro drug release profiles in 0.1 N HCl and pH 6.8 phosphate buffer was observed with all dispersions, especially the coevaporate. The coevaporate, when administered orally in rats, also exhibited improved in vivo activity, as measured by net sodium ion excretion, as compared with triamterene powder. Thus, coevaporation of the drug and β-cyclodextrin from acidified alcohol provide the optimum condition for inclusion complexation to give a binary system with remarkable improvement in in vitro drug release profile and in vivo performance.